|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
24,740,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.35 - $0.35 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Woloshen Daniel S |
Senior VP and General Counsel |
|
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
30,491 |
95,825 |
|
- |
|
Bechon Christian |
Director |
|
2008-02-12 |
4 |
B |
$0.87 |
$1,756,011 |
I/I |
2,018,404 |
5,648,404 |
2.1 |
- |
|
Lfb Biotechnologies S.a.s.u. |
10% Owner |
|
2008-02-12 |
4 |
B |
$0.87 |
$1,756,011 |
D/D |
2,018,404 |
5,648,404 |
2.45 |
- |
|
Scotland Richard A |
Senior VP, Regulatory Affairs |
|
2008-01-04 |
4 |
A |
$0.72 |
$501 |
D/D |
693 |
54,329 |
|
- |
|
Cox Geoffrey F |
President, CEO and Chairman |
|
2008-01-04 |
4 |
A |
$0.72 |
$501 |
D/D |
693 |
254,675 |
|
- |
|
Tuck Alan W |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$1,000 |
D/D |
1,149 |
6,683 |
|
- |
|
Miller Marvin |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$1,200 |
D/D |
1,379 |
8,229 |
|
- |
|
Mcnamara Pamela W |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$1,000 |
D/D |
1,149 |
8,677 |
|
- |
|
Geraghty James A |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$2,750 |
D/D |
3,161 |
86,946 |
|
- |
|
Bechon Christian |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$5,000 |
D/D |
5,747 |
18,415 |
|
- |
|
Bullock Francis J |
Director |
|
2007-12-28 |
4 |
A |
$0.87 |
$1,875 |
D/D |
2,155 |
10,655 |
|
- |
|
Gray Mary Ann |
Director |
|
2007-12-17 |
4 |
B |
$0.88 |
$8,800 |
D/D |
10,000 |
11,000 |
2.39 |
- |
|
Woloshen Daniel S |
Senior VP and General Counsel |
|
2007-12-17 |
4 |
B |
$0.89 |
$1,068 |
D/D |
1,200 |
65,334 |
2.66 |
- |
|
Geraghty James A |
Director |
|
2007-12-14 |
4 |
B |
$0.87 |
$8,696 |
D/D |
10,000 |
83,785 |
2.39 |
- |
|
Liposky Gregory F |
Senior VP, Operations |
|
2007-12-14 |
4 |
B |
$0.87 |
$957 |
D/D |
1,100 |
34,648 |
2.66 |
- |
|
Green John B |
Senior VP and CFO |
|
2007-12-14 |
4 |
B |
$0.89 |
$1,334 |
D/D |
1,500 |
87,200 |
2.66 |
- |
|
Meade Harry |
SVP, Transgenic Research |
|
2007-12-14 |
4 |
B |
$0.90 |
$9,000 |
D/D |
10,000 |
99,226 |
2.74 |
- |
|
Cox Geoffrey F |
President, CEO and Chairman |
|
2007-12-13 |
4 |
B |
$0.88 |
$9,581 |
D/D |
10,765 |
253,982 |
2.81 |
- |
|
Gray Mary Ann |
Director |
|
2007-12-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
Cox Geoffrey F |
President, CEO and Chairman |
|
2007-10-05 |
4 |
A |
$0.88 |
$1,108 |
D/D |
1,253 |
243,217 |
|
- |
|
Scotland Richard A |
Senior VP, Regulatory Affairs |
|
2007-10-05 |
4 |
A |
$0.88 |
$1,114 |
D/D |
1,260 |
53,636 |
|
- |
|
Miller Marvin |
Director |
|
2007-09-28 |
4 |
A |
$1.02 |
$1,200 |
D/D |
1,176 |
6,850 |
|
- |
|
Tuck Alan W |
Director |
|
2007-09-28 |
4 |
A |
$1.02 |
$1,000 |
D/D |
980 |
5,534 |
|
- |
|
Bechon Christian |
Director |
|
2007-09-28 |
4 |
A |
$1.02 |
$5,000 |
D/D |
4,902 |
12,668 |
|
- |
|
Geraghty James A |
Director |
|
2007-09-28 |
4 |
A |
$1.02 |
$2,750 |
D/D |
2,696 |
73,785 |
|
- |
|
211 Records found
|
|
Page 5 of 9 |
|
|